About
Carole Ben-Maimon, M.D., is a biopharmaceutical executive and physician who leads Larimar Therapeutics, a rare-disease drug developer. She previously led Chondrial, served as President of Global Pharmaceuticals at Impax Laboratories, and held senior roles at Barr, Teva, and other pharmaceutical companies. She also serves on corporate and nonprofit boards, including Bionpharma.
Areas of interest
biotechrare disease therapeuticspharmaceuticalsgeneric pharmaceuticalsdrug developmentclinical medicinewomen's health